Thursday, 11 August, 2022, 5:24 AM
Advance Search
latest
Home Business

Beximco introduces anti-Covid tablet in Bangladesh

Published : Thursday, 30 December, 2021 at 8:22 PM  Count : 966

Beximco introduces anti-Covid tablet in Bangladesh

Beximco introduces anti-Covid tablet in Bangladesh

Beximco Pharma has announced the launch of the world's first generic version of Pfizer's COVID-19 treatment Paxlovid which was granted emergency use authorization (EUA) by the US FDA on December 22.

Directorate General of Drug Administration (DGDA), Bangladesh granted EUA for the oral antiviral drug on 30 December 2021 to treat mild-to-moderate COVID-19 in adults and children of 12 years and above, said a press release on Thursday. 

This novel antiviral pill showed almost 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent data from Pfizer suggests the drug retains its effectiveness against the fast-spreading Omicron variant of the coronavirus.

Beximco Pharma will market this product under the brand name Bexovid, initially in Bangladesh.

The treatment is given as two tablets of nirmatrelvir and one tablet of ritonavir together twice a day for five days.

Bexovid is available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset.

Nazmul Hassan, Managing Director of Beximco Pharmaceuticals, said, "Having previously introduced the world's first generic COVID-19 treatments of remdesivir and molnupiravir, we are pleased to add this breakthrough therapy to our portfolio. It is further testament to our commitment to making affordable treatments accessible as soon as possible."

"As data continues to emerge demonstrating the effectiveness of nirmatrelvir and ritonavir against the the fast-emerging Omicron variant, we believe that Bexovid has the potential to be a powerful tool in combating the ongoing pandemic."

GY



« PreviousNext »



Latest News
Most Read News
Editor : Iqbal Sobhan Chowdhury
Published by the Editor on behalf of the Observer Ltd. from Globe Printers, 24/A, New Eskaton Road, Ramna, Dhaka.
Editorial, News and Commercial Offices : Aziz Bhaban (2nd floor), 93, Motijheel C/A, Dhaka-1000. Phone: PABX 223353467, 223353481-2; Online: 9513959; Advertisement: 9513663.
E-mail: [email protected], [email protected], [email protected], [email protected],   [ABOUT US]     [CONTACT US]   [AD RATE]   Developed & Maintenance by i2soft